Dr John Bashford, research director at the Icon Group, spoke with BioPharmaDispatch about its approach to cancer care and clinical trials using targeted therapy and immunotherapy. …
Latest Video
New Stories
-
Trump administration announces new disclosure rules for medicine advertising
September 10, 2025 - - Latest News -
Chemist Warehouse partners with DoorDash to deliver health and beauty on demand
September 10, 2025 - - Latest News -
Cancer leaders unite to tackle equity and innovation at 2025 PCPA Summit
September 10, 2025 - - Latest News -
Roche Australia links health to sustainability in new report
September 10, 2025 - - Latest News -
Pathkey’s AI shows promise in predicting clinical trial success
September 9, 2025 - - Australian Biotech -
Final TrailblAZers episode highlights lessons from the pandemic and the future of health policy
September 9, 2025 - - Podcast -
IP Australia flags streamlined patent opposition process for pharmaceutical sector
September 8, 2025 - - Latest News